Advertisement

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma

Anja Mottok, Stacy S. Hung, Elizabeth A. Chavez, Bruce Woolcock, Adèle Telenius, Lauren C. Chong, Barbara Meissner, Hisae Nakamura, Christopher Rushton, Elena Viganò, Clementine Sarkozy, Randy D. Gascoyne, Joseph M. Connors, Susana Ben-Neriah, Andrew Mungall, Marco A. Marra, Reiner Siebert, David W. Scott, Kerry J. Savage and Christian Steidl

Article Information

Citation 
vol. 134 no. 10 802-813
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 14, 2019
  • Accepted June 28, 2019
  • Published online September 5, 2019.

Article Versions


Contributors 
  • Anja Mottok, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada; 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; 3Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;
  • Stacy S. Hung, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Elizabeth A. Chavez, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Bruce Woolcock, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Adèle Telenius, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Lauren C. Chong, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Barbara Meissner, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Hisae Nakamura, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Christopher Rushton, 4Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada; and
  • Elena Viganò, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Clementine Sarkozy, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Randy D. Gascoyne, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada; 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;
  • Joseph M. Connors, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Susana Ben-Neriah, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Andrew Mungall, 5British Columbia Cancer, Canada’s Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
  • Marco A. Marra, 5British Columbia Cancer, Canada’s Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
  • Reiner Siebert, 3Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;
  • David W. Scott, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Kerry J. Savage, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada;
  • Christian Steidl, 1British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada; 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output